LY2828360   Click here for help

GtoPdb Ligand ID: 12751

Synonyms: compound 26 [PMID: 23795771] | LY-2828360
Compound class: Synthetic organic
Comment: LY2828360 is a selective cannabinoid receptor type 2 (CB2) agonist [1]. It is reported to exhibit G protein-biased signalling, and does not recruit arrestin [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 0
Rotatable bonds 3
Topological polar surface area 56.03
Molecular weight 426.94
XLogP 2.16
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=NC(=C2C(=N1)N(C3CCOCC3)C(=N2)C4=CC=CC=C4Cl)N5CCN(C)CC5
Isomeric SMILES CC1=NC2=C(C(=N1)N3CCN(CC3)C)N=C(N2C4CCOCC4)C5=CC=CC=C5Cl
InChI InChI=1S/C22H27ClN6O/c1-15-24-21(28-11-9-27(2)10-12-28)19-22(25-15)29(16-7-13-30-14-8-16)20(26-19)17-5-3-4-6-18(17)23/h3-6,16H,7-14H2,1-2H3
InChI Key UCMNDPDJRSEZPL-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
LY2828360 was advanced to clinical trial, to determine analgesic efficacy in acute inflammatory pain.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT01319929 A Study of LY2828360 in Patients With Osteoarthritic Knee Pain Phase 2 Interventional Eli Lilly and Company